Methods for treating cancer
US10143704B2 · kind B2 · utility
4Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2014 |
| Grant date | Dec 4, 2018 |
| Priority date | — |
| Expiry date | Nov 13, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.